[PDF] Guidance for clinical trials for children and adolescents with chronic Hepatitis C

Source:
European Society for Paediatric Gastroenterology Hepatology and Nutrition
Publisher:
European Society for Paediatric Gastroenterology Hepatology and Nutrition
Publication date:
01 February 2011

Abstract

Children with chronic hepatitis C are at risk of cirrhosis and cancer. Combination drug therapy using pegylated interferon-a and ribavirin has improved the outcome and diagnosis of the disease and has improved viral clearance rates.